ES487035A0 - Un procedimiento para la obtencion de agentes bloqueantes dereceptor h2 de la histamina - Google Patents
Un procedimiento para la obtencion de agentes bloqueantes dereceptor h2 de la histaminaInfo
- Publication number
- ES487035A0 ES487035A0 ES487035A ES487035A ES487035A0 ES 487035 A0 ES487035 A0 ES 487035A0 ES 487035 A ES487035 A ES 487035A ES 487035 A ES487035 A ES 487035A ES 487035 A0 ES487035 A0 ES 487035A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- obtaining
- blocking agents
- histamine blocking
- histamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/970,517 US4200578A (en) | 1978-12-18 | 1978-12-18 | Thiazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES487035A0 true ES487035A0 (es) | 1980-12-16 |
ES8101569A1 ES8101569A1 (es) | 1980-12-16 |
Family
ID=25517073
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES487035A Expired ES8101569A1 (es) | 1978-12-18 | 1979-12-18 | Un procedimiento para la obtencion de agentes bloqueantes dereceptor h2 de la histamina |
ES493718A Expired ES8106715A1 (es) | 1978-12-18 | 1980-07-24 | Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES493718A Expired ES8106715A1 (es) | 1978-12-18 | 1980-07-24 | Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina |
Country Status (24)
Country | Link |
---|---|
US (1) | US4200578A (es) |
JP (1) | JPS5583768A (es) |
KR (3) | KR830001920B1 (es) |
AT (1) | AT375354B (es) |
AU (1) | AU533014B2 (es) |
BE (1) | BE880662A (es) |
CA (1) | CA1133909A (es) |
CH (1) | CH642956A5 (es) |
DE (1) | DE2950838A1 (es) |
DK (1) | DK533979A (es) |
ES (2) | ES8101569A1 (es) |
FI (1) | FI793904A (es) |
FR (1) | FR2444674B1 (es) |
GB (1) | GB2038822B (es) |
GR (1) | GR73586B (es) |
HU (1) | HU182461B (es) |
IE (1) | IE49320B1 (es) |
IL (1) | IL58960A (es) |
IT (1) | IT1164076B (es) |
LU (1) | LU82000A1 (es) |
NL (1) | NL7909054A (es) |
SE (1) | SE444680B (es) |
YU (3) | YU292179A (es) |
ZA (1) | ZA796814B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE31588E (en) * | 1977-06-03 | 1984-05-22 | Bristol-Myers Company | Imidazolylmethylthioethyl alkynyl guanidines |
GR71929B (es) * | 1979-11-13 | 1983-08-19 | Ici Ltd | |
US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
US4904792A (en) * | 1980-10-02 | 1990-02-27 | Eli Lilly And Company | N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds |
US4760075A (en) * | 1980-10-02 | 1988-07-26 | Eli Lilly And Company | N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds |
NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
US4474794A (en) * | 1982-03-19 | 1984-10-02 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds |
US4458077A (en) * | 1982-11-22 | 1984-07-03 | American Home Products Corporation | Heterocyclic anti-ulcer agents |
JPS59104370A (ja) * | 1982-12-03 | 1984-06-16 | Kotobuki Seiyaku Kk | チアゾ−ル誘導体及びその製造方法 |
DK164501C (da) * | 1983-02-07 | 1992-11-23 | Lilly Co Eli | Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden |
CA1277325C (en) * | 1985-12-18 | 1990-12-04 | Bruce A. Slomski | Synthesis of nizatidine |
JPH0247453U (es) * | 1988-09-29 | 1990-03-30 | ||
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
CN111974333B (zh) * | 2020-08-19 | 2023-06-09 | 宁夏亚东化工有限公司 | 噻唑生产线及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE758146A (fr) * | 1969-10-29 | 1971-04-28 | Smith Kline French Lab | Derives de l'amidine |
GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
BE804144A (en) | 1972-09-05 | 1974-02-28 | Smith Kline French Lab | H-2-Receptor antihistamines esp gastric acid inhibitors - -N-cyano-N"-(heterocyclyl-alkyl-(thio oxa amino or methylene-alkyl)-guanidines |
US4072748A (en) * | 1972-09-05 | 1978-02-07 | Smith Kline & French Laboratories Limited | Certain guanidine compounds, and their use as inhibitors of histamine activity |
GB1421792A (en) | 1973-05-17 | 1976-01-21 | Smith Kline French Lab | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
GB1553070A (en) | 1975-05-21 | 1979-09-19 | Smith Kline French Lab | Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives |
NO781300L (no) | 1977-04-20 | 1978-10-23 | Ici Ltd | Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater |
US4112234A (en) * | 1977-08-22 | 1978-09-05 | Bristol-Myers Company | Imidazolylmethylthioethyl alkynyl guanidines |
-
1978
- 1978-12-18 US US05/970,517 patent/US4200578A/en not_active Expired - Lifetime
-
1979
- 1979-11-13 CA CA339,769A patent/CA1133909A/en not_active Expired
- 1979-11-28 YU YU02921/79A patent/YU292179A/xx unknown
- 1979-11-29 GR GR60634A patent/GR73586B/el unknown
- 1979-12-04 IT IT50977/79A patent/IT1164076B/it active
- 1979-12-11 AU AU53716/79A patent/AU533014B2/en not_active Ceased
- 1979-12-11 CH CH1097579A patent/CH642956A5/fr not_active IP Right Cessation
- 1979-12-11 GB GB7942660A patent/GB2038822B/en not_active Expired
- 1979-12-13 FR FR7930603A patent/FR2444674B1/fr not_active Expired
- 1979-12-13 FI FI793904A patent/FI793904A/fi not_active Application Discontinuation
- 1979-12-14 ZA ZA00796814A patent/ZA796814B/xx unknown
- 1979-12-14 DK DK533979A patent/DK533979A/da not_active Application Discontinuation
- 1979-12-14 IL IL58960A patent/IL58960A/xx unknown
- 1979-12-14 NL NL7909054A patent/NL7909054A/nl not_active Application Discontinuation
- 1979-12-17 JP JP16289979A patent/JPS5583768A/ja active Granted
- 1979-12-17 IE IE2436/79A patent/IE49320B1/en unknown
- 1979-12-17 BE BE0/198600A patent/BE880662A/fr not_active IP Right Cessation
- 1979-12-17 LU LU82000A patent/LU82000A1/de unknown
- 1979-12-17 AT AT0793779A patent/AT375354B/de not_active IP Right Cessation
- 1979-12-17 SE SE7910392A patent/SE444680B/sv unknown
- 1979-12-18 DE DE19792950838 patent/DE2950838A1/de not_active Withdrawn
- 1979-12-18 ES ES487035A patent/ES8101569A1/es not_active Expired
- 1979-12-18 KR KR7904488A patent/KR830001920B1/ko active
- 1979-12-18 HU HU79BI600A patent/HU182461B/hu unknown
-
1980
- 1980-07-24 ES ES493718A patent/ES8106715A1/es not_active Expired
-
1982
- 1982-11-19 YU YU02594/82A patent/YU259482A/xx unknown
- 1982-11-19 YU YU02593/82A patent/YU259382A/xx unknown
-
1983
- 1983-04-14 KR KR1019830001579A patent/KR840001074B1/ko not_active IP Right Cessation
- 1983-04-14 KR KR1019830001578A patent/KR840001075B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES494300A0 (es) | Un procedimiento para la preparacion de carboxialquil-dipep-tidos | |
ES489126A0 (es) | Un procedimiento para la preparacion de un isocianato | |
ES485670A0 (es) | Un procedimiento para la preparacion de n-(2-sustituido-4-piridil-ureas | |
ES495892A0 (es) | Un procedimiento para la preparacion de metacroleina | |
ES487035A0 (es) | Un procedimiento para la obtencion de agentes bloqueantes dereceptor h2 de la histamina | |
ES490213A0 (es) | Un procedimiento para la preparacion de fenetanolaminas | |
ES474764A0 (es) | Un procedimiento para la preparacion de ftalazinas. | |
ES487380A0 (es) | Un procedimiento para la preparacion de supositorios estables | |
ES489470A0 (es) | Un procedimiento para la preparacion de 9-aminoalquilfluore-no | |
AR222511A1 (es) | Un procedimiento para la preparacion de 11-acetil-4"-deoxi-4"-furfurilamino-oleandomicina" | |
ES493111A0 (es) | Un procedimiento de preparacion de nuevas fenoxiaminas hete-rociclicas | |
ES491370A0 (es) | Un procedimiento para la preparacion de piridizinobenzodiazepinas | |
ES493204A0 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
ES493506A0 (es) | Un procedimiento para la preparacion de desacetil-cefalospo-rina c | |
AR219321A1 (es) | Procedimiento para la fabricacion de un recipiente | |
ES490022A0 (es) | Un procedimiento para la preparacion de imidazobenzodiacepi-nas | |
AR222147A1 (es) | Un procedimiento para la preparacion de compuestos de 4"-deixo-4"-amino-eritromicina"a" | |
AR210207A1 (es) | Un procedimiento para la preparacion de nuevas nicotinoilamino triacinas | |
ES489355A0 (es) | Un procedimiento para la preparacion de nuevos piretroides | |
ES490208A0 (es) | Un procedimiento para la preparacion de nuevas 3-fenilpropi-laminas n-sustituidas | |
ES491662A0 (es) | Un procedimiento para la preparacion de un pirazol cuaterna-rio | |
ES493200A0 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
ES490287A0 (es) | Un procedimiento para la preparacion de 2-aminopirazinas | |
ES492539A0 (es) | Un procedimiento para la preparacion de pirencepina | |
ES489540A0 (es) | Un procedimiento para la preparacion de 4-hidroximetil-5-me-tilimidazol |